TeselaGen Biotechnology

teselagen.com

TeselaGen's artificial Intelligence powered platform radically accelerates product development of therapeutics, high value chemicals, and agricultural products. We are located in San Francisco.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

MULTISTAKEHOLDER COLLABORATIONS ARE VITAL TO ADVANCING TECHNOLOGIES IN PARKINSON'S

PRNewswire | July 10, 2023

news image

Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Rochester today announced the release of two seminal publications about digital health technologies for Parkinson's. These technologies, such as smartphones and wearable sensors, offer an opportunity for objective, frequent and remote assessment of people with Parkinson's. With 10 million people living with Parkinson's worldwide, collaboration and data sharing are crucial ...

Read More

AMAG PHARMACEUTICALS ANNOUNCES CHANGES TO MEDICAL DEVELOPMENT ORGANIZATION

Send Press Releases with GlobeNewswire | March 04, 2020

news image

AMAG Pharmaceuticals, Inc. today announced changes to its medical development organization. Effective March 31, 2020, Julie Krop, M.D., Executive Vice President and Chief Medical Officer, will be leaving the Company. As AMAG initiates a search for a permanent Chief Medical Officer, the Board of Directors and management will continue to work closely with the medical development organization on key priorities, including working with the U.S. Food and Drug Administration (FDA) to find a path to ret...

Read More

MEDIDATA, TRINETX, AND DATAVANT PARTNER TO ENABLE SEAMLESS INTEGRATION OF REAL-WORLD DATA IN CLINICAL DEVELOPMENT

Medidata | October 30, 2020

news image

Medidata, a Dassault Systèmes company, TriNetX, and Datavant announced a partnership that will accelerate the use of real-world data (RWD) to power clinical research. Linking RWD, which are data not collected during the specific context of the trial, can help improve understanding of the long-term safety and efficacy of new therapies. This partnership will enable users of Medidata’s end-to-end clinical research platform to securely link their clinical data with patient consent to de...

Read More

Pharmacy Market

NEXUS PHARMACEUTICALS RECEIVES FDA APPROVAL FOR 0.9% SODIUM CHLORIDE INJECTION

businesswire | August 31, 2023

news image

Nexus Pharmaceuticals LLC announced it has received U.S. Food and Drug Administration (FDA) approval for 0.9% Sodium Chloride Injection, USP in 10mL and 20mL Single-Dose Vials. “This product is part of an expanding portfolio of products that address critical healthcare challenges,” said Omair Ahmed, Chief Operating Officer. “Sodium Chloride Injection is used to treat patients every day in every hospital in the United States. We are grateful to be able to bolste...

Read More
news image

Pharma Tech

MULTISTAKEHOLDER COLLABORATIONS ARE VITAL TO ADVANCING TECHNOLOGIES IN PARKINSON'S

PRNewswire | July 10, 2023

Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Rochester today announced the release of two seminal publications about digital health technologies for Parkinson's. These technologies, such as smartphones and wearable sensors, offer an opportunity for objective, frequent and remote assessment of people with Parkinson's. With 10 million people living with Parkinson's worldwide, collaboration and data sharing are crucial ...

Read More
news image

AMAG PHARMACEUTICALS ANNOUNCES CHANGES TO MEDICAL DEVELOPMENT ORGANIZATION

Send Press Releases with GlobeNewswire | March 04, 2020

AMAG Pharmaceuticals, Inc. today announced changes to its medical development organization. Effective March 31, 2020, Julie Krop, M.D., Executive Vice President and Chief Medical Officer, will be leaving the Company. As AMAG initiates a search for a permanent Chief Medical Officer, the Board of Directors and management will continue to work closely with the medical development organization on key priorities, including working with the U.S. Food and Drug Administration (FDA) to find a path to ret...

Read More
news image

MEDIDATA, TRINETX, AND DATAVANT PARTNER TO ENABLE SEAMLESS INTEGRATION OF REAL-WORLD DATA IN CLINICAL DEVELOPMENT

Medidata | October 30, 2020

Medidata, a Dassault Systèmes company, TriNetX, and Datavant announced a partnership that will accelerate the use of real-world data (RWD) to power clinical research. Linking RWD, which are data not collected during the specific context of the trial, can help improve understanding of the long-term safety and efficacy of new therapies. This partnership will enable users of Medidata’s end-to-end clinical research platform to securely link their clinical data with patient consent to de...

Read More
news image

Pharmacy Market

NEXUS PHARMACEUTICALS RECEIVES FDA APPROVAL FOR 0.9% SODIUM CHLORIDE INJECTION

businesswire | August 31, 2023

Nexus Pharmaceuticals LLC announced it has received U.S. Food and Drug Administration (FDA) approval for 0.9% Sodium Chloride Injection, USP in 10mL and 20mL Single-Dose Vials. “This product is part of an expanding portfolio of products that address critical healthcare challenges,” said Omair Ahmed, Chief Operating Officer. “Sodium Chloride Injection is used to treat patients every day in every hospital in the United States. We are grateful to be able to bolste...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us